Consulting company specialized in market access and reimbursement of medical devices (MD), in vitro diagnostic medical devices (IVD) and various innovative health technologies (e-health and artificial intelligence).
SGE Consulting was delighted to participate in the AFCROs Real World Data (RWD) working group’s presentation on the new National Health Data System (SNDS) guide for a relevant use of these data. This presentation consolidates our knowledge on the exploitation
Sylvia Germain, founder and President at SGE Consulting for over 5 years, is delighted to announce that Gaëlle Boterf has joined the company as a Market Access & Corporate Strategy Director. Gaëlle has over 20 years of experience in the
SGE Consulting is pleased to announce the publication of the thesis by its Market access consultant – Romain Joret, Doctor of Pharmacy. Romain Joret joined SGE Consulting as a consultant specialized in Market Access and Reimbursement for innovative health technologies
Following the French Prime Minister’s announcement, SGE Consulting is reinforcing its telecommuting measures already in effect since March 2020. An office rotation schedule has been established in accordance with the government’s directives to telework 4 days out of 5 and
SGE Consulting is pleased to invite you to our next Webinar organized in collaboration with HEVA (in English). The topic is the use of health data in market access strategies across the lifecycle of health technologies. We look forward to
SGE Consulting will have the opportunity to participate in the presentation of 2 posters during Virtual ISPOR Europe 2020, 16-19 November 2020. These publications concern the Impella 5.0® and Impella CP® technologies of the Abiomed company. Impella 5.0®, a short